Schrodinger is trading 5.8% up at $18.69, with no clearly reported company-specific catalyst identified for August 19, 2026.
- Recent coverage includes its August 5 earnings beat and Bristol Myers Squibb AI collaboration, but neither event is fresh enough to directly explain the current move.
- Broader markets are mixed, with the Nasdaq down 0.39%, so macro sentiment does not clearly account for Schrodinger’s gain.